A B S T R A C T Pituitary and gonadal function was studied in seven chromatin-negative men, ages 15-27 yr, with retarded sexual and somatic development, skeletal anomalies, and hyposnmia. These hyposmic patients were compared with normal men, prepuberal boys and hypogonadal patients with hypopituitarism. The urinary follicle-stimulating hormone (FSH) and luteinizing hormone (LH) levels of hyposmic subjects were the same as those of normal boys and hypopituitary patients but significantly lower than those of normal men. Clomiphene citrate did not cause an increase in plasma FSH and LH levels in either hypogonadal group as it does in normal men. In contrast to hypopituitary patients, thyroid and adrenocortical function and release of growth hormone in the hyposmic subjects were normal. The plasma testosterone levels were equally low in prepuberal, hypopituitary, and hyposmic patients but were increased to a greater extent by human chorionic gonadotropin (HCG) treatment in prepuberal and hypopituitary subjects than in the hyposmic patients. Prolonged treatment with HCG has failed to return plasma testosterone levels to normal in two hyposmic patients. These observations suggest that there are defects of both pituitary and Leydig cell function in men with the syndrome of hypogonadism, skeletal anomalies, and hyposmia. They have impaired secretion of FSH and LH and a Leydig cell insensitivity to gonadotropin.
INTRODUCTION
Defective olfaction has been noted in patients with hypogonadotropic hypogonadism for many years. This association has been reported in individual patients (1) and in members of several kindreds (2) (3) (4) . Despite the early recognition of patients with these signs, only with the recent development of precise methods for estimation of plasma androgens and gonadotropins have studies of the pituitary-Leydig cell axis of these patients been possible. To better understand this type of hypogonadism, the dynamics of gonadotropin and testosterone secretion were studied in seven males with hypogonadotropic hypogonadism and hyposmia. Comparable studies were carried out in normal men and in two other groups of hypogonadal subjects: "normal" prepuberal boys and patients with hypopituitarism.
METHODS
Methods were as follows: total urinary gonadotropins (5); urinary 17-hydroxysteroids (6) ; plasma cortisol (7) ; plasma leutinizing hormone (LH) (8) ; plasma follicle-stimulating hormone (FSH) (9) ; plasma growth hormone (10) ; and plasma testosterone (11) . Urinary FSH and LH excretion were measured in normal men and children by bioassay (12, 13) of extracts of large pools of urine (14) . Since we showed subsequently that LH and FSH activity in urine extracts could be estimated by radioimmunoassay (9, 15) on aliquots of a single 24 Tests of hypothalamic-pituitary and testicular function were performed as follows: a bacterial pyrogen' was given intravenously at 0.6 Ag/kg and blood obtained at 0, 1, 2, and 4 hr. A normal response is defined as a doubling of plasma cortisol concentrations and an increase of plasma growth hormone to greater than 10 mug/ml (16) . Arginine' (500 mg/kg) was infused for 0.5 hr and plasma obtained at 30-min intervals for 1.5 hr after the end of the infusion. In normal subjects plasma immunoreactive growth hormone levels increased to 10 mig/ml or more (17) . Insulin, 0.1 U/kg intravenously in normal subjects, increased plasma growth hormone to at least 10 mug/ml when the blood sugar decreased 50%o. Clomiphene citrate was given by mouth 200 mg daily for 6 days and induced mean increases of 160 and 130%o in plasma LH and FSH levels respectively in normal men (18, 19) . Human chorionic gonadotrophin (HCG), (APL, Ayerst Laboratories, New York), 4000 U intramuscularly daily for 4 days, caused at least a 100% increase in plasma testosterone levels in normal men (20) . Metyrapone, 750 mg every 4 hr, caused a doubling of urinary 17-hydroxycorticoids in normal subjects. Except for the last, these tests have been standardized in this laboratory in normal men, ages 21-45 yr.
Hyposmic patients. Seven male subjects, ages 15-27 yr, with hyposmia and hypogonadism were studied. They were referred to our clinic because of retarded sexual development and a eunuchoidal habitus. All had clinically evident hyposmia, and there was difficulty with recognition of a variety of substances such as coffee, wintergreen, and cloves. Two subjects had nerve deafness, and one of them was color-blind. The karyotype was 46, XY and the nuclear sex was chromatin negative in all seven subjects. Short fourth metacarpals were present by X-ray examination in four patients. The testes were either high in the inguinal canal or within the abdomen in four of the patients. Testicular biopsy was performed in all patients. The hyposmic patients had no family history of hypogonadism, and from a total of 15 siblings (10 sisters, five brothers), six women and two men were fertile. Pertinent clinical and laboratory features of each case are given in the Appendix and in Table I Fig. 7 . DISCUSSION According to De Morsier defective olfaction accompanying hypogonadism was noted as early as 1850 (22) . In 1944 Kallman and associates (2) reviewed the earlier reports of this association and emphasized its hereditary aspects by describing three involved kindreds. Some of the patients described by these investigators had color blindness, synkinesia, mental retardation, and nerve deafness in addition to anosmia and hypogonadism. In recent years additional kindreds and individual patients with hypogonadism and defective olfaction have been reported (1, 3, 4) . In the present series, no family history of hypogonadism could be elicited, but a high incidence of extragenital and extragonadal anomalies were noted.
All our patients had hyposmia (rather than anosmia) as did the members of the family described by Henkin (23) . In addition to this sensory defect, color blindness and nerve deafness were present in two. Four patients had undescended testes, and four had short fourth metacarpals.
In addition to the hyposmic patients described above there are several syndromes-in which secondary hypogonadism may occur in association with a variety of neurological and somatic abnormalities. In the LaurenceMoon Biedl syndrome, mental retardation, retinitis pigmentosa, and many other anomalies occur in a familial pattern with hypogonadotropic hypogonadism (24, 25). Similarly, familial cerebellar ataxia has been associated with nerve deafness and secondary hypogonadism (26, 27) . Although not described as part of cerebellar ataxia or the Laurence-Moon-Biedl syndrome, short fourth metacarpals were present in the X-rays of such patients (24, 27) . Hypogonadotropic hypogonadism has also been associated with other familial diseases such as diabetes mellitus and hyperlipemia (28) . Even though patients with gynecomastia, hypoandrogenization, and low gonadotropin excretion may have a primary defect of gonadotropin production, increased blood estrogens could also produce these same clinical and laboratory findings (29) ; a clomiphene stimulation test should be useful in this distinction. To further add to the heterogeneity of these syndromes, primary hypogonadism has also been described in patients with Laurence-Moon-.Biedl syndrome (29) and familial ataxia (30 (31, 32) . These features include eunuchoidal body proportions, delayed bone age, small soft testes, and decreased development of androgen-dependent tissues and organs. In addition to these signs which are attributed to hypogonadotropism per se, our patients had hyposmia, bony anomalies, and cryptorchidism. These latter features make possible a presumptive diagnosis of hypogonadotropic hypogonadism even before the expected age of puberty.
Despite the clinical usefulness of the total gonadotropin assay it is inadequate for easy quantification at low levels. Recently the LH and FSH excretion of children has been determined by both bioassay and radioimmunoassay. These two assays gave comparable results and indicated that the concentrations of LH and FSH in the urine of normal children is one-tenth and one-half as much as that in normal adult males, respectively (9, 14, 15) . From our limited experience with hypogonadal subjects we would conclude that the urinary concentration of LH and FSH in some hypopituitary and hyposmic patients may be the same as those of normal children. Furthermore it is apparent that the hyposmic pa- It was therefore pertinent to investigate the effect of clomiphene on the plasma gonadotropin levels of the boys with hyposmia and hypogonadism. In five patients with low plasma testosterone levels increases of plasma LH and FSH were not observed, whereas patient No. 4 (plasma testosterone, 0.2 ,g/100 ml) had a definite increase of plasma LH during clomiphene. These observations are in keeping with one theory proposed for clomiphene action which states that an antiestrogen (or antiandrogen) increases gonadotropin secretion by interrupting the negative feedback of gonadal steroids on the central nervous system. Since the hyposmic subjects have not developed the normal negative feedback system, the low testosterone level fails to elicit an appropriate increase in plasma gonadotropins, and further interruption of androgen action on the brain by clomiphene does not facilitate LH and FSH secretion.
The hyposmic patients we have described have hypogonadotropism without any other detectable anterior pituitary hormonal deficiency. Whether the gonadotropin deficit is the result of an isolated pituitary abnormality or a defect in the central nervous system is not known with certainty. There is no direct evidence to suggest that an intrinsic abnormality of the gonadotropinproducing cell of the pituitary is responsible for the hypogonadotropism. Alternatively, the association of abnormalities in the central nervous system and hypogonadotropism suggests that they could be causally related. In this regard hypoplasia of the hypothalamus and mammillary bodies has been reported in several autopsied cases (33) , but in these patients other parameters of pituitary function were not carefully assessed. Furthermore, the association of hypogonadotropism with hyposmia is even more intriguing since olfaction is necessary for sexual attraction and arousal in many species. The olfactory apparatus is phylogenetically part of the rhinencephalon, and the amygdaloid nuclei in this portion of the brain may be important for controlling the onset of puberty (34, 35) . Thus a diffuse abnormality of rhinencephalic function could relate hyposmia and hypogonadotropism. However, the occurrence of hypogonadotropic hypogonadism alone and in association with a variety of other neurological defects indicates that the gonadotropin deficiency may occur independent of the hyposmia. Thus it would appear that an exact neuroanatomical correlation between an affected area of the brain and hypogonadotropism has not been established.
Testosterone secretion. During fetal life the testes secrete an androgen which is responsible for development of the external genitalia of the male. The presence of a normal phallus and scrotum in each of the hyposmic boys suggests that the gonad was active during fetal life. During the 1st yr of life the Leydig cells which are present at birth in the normal testes regress and are not usually recognizable histologically again until the time of puberty. The testes of patients with hypopituitarism and of the hyposmic boys were morphologically similar to those of the child, since Leydig cells were identified with difficulty. Reduced or "absent" Laydig cells is a common finding in patients with hypogonadotropic hypogonadism (31) .
HCG has been used for many years as a test of Leydig cell function and for the treatment of secondary hypogonadism in man. Its efficacy is due to its ability to stimulate testosterone production (20) . Several investigators have also shown that HCG can increase testosterone excretion in children (36) (37) (38) . Stuiver, Thijssen, and Van der Molen (39) demonstrated a uniform increase in the plasma testosterone of boys (age 15-17 yr) with "delayed puberty," but there was a more variable response in hypopituitary patients. While it is impossible to compare quantitative results from two laboratories, it is noteworthy that these results are qualitatively similar to those obtained in our normal and hypopituitary patients. In the present study the response of the Leydig cells of three groups of hypogonadotropic subjects were compared. As a group the hyposmic boys were less responsive to 4 days of HCG than were the normal boys and hypopituitary patients.
Kallman et al (2) indicated that three of their patients with hypogonadism and anosmia failed to respond clinically to HCG administration, and there is brief mention of similar observations by several other investigators (1, 40, 41) , including a patient with Laurence-Moon-Biedl syndrome (24 Patient 2. D. F. contracted chicken pox, bilateral otitis media, and pneumonia at 6 months of age. At 1 yr he was noted to be deaf. Between the ages of 9 and 11 yr he received several long courses of HCG for bilateral cryptorchidism. The testes did not descend, and axillary and pubic hair did not develop during HCG therapy. A right inguinal herniorrhaphy was performed at age 12 yr. At 14 yr he was referred to us. He had nerve deafness, color blindness, left amblyopia exanopsia with heterochromia of irides, and decreased vision in the left eye. His penis was infantile, and there was no palpable prostate. The small right testis (1 X 1.5 cm) was high in the inguinal canal, but the left testis was not palpable. Treatment with fluoxymestrone, 5 mg/day, caused secondary sexual development.
Patient 3. H. C. was rejected by the army at age 18 because of failure to develop. The patient's father, however, had not undergone puberty until age 20 yr. He was referred to our service at age 20 at which time his penis and testes were infantile and the prostate was not palpable. After the studies were completed the patient received fluoxymestrone, 5 mg/day, with adequate virilization.
PatieOt 4. PH was thought to have delayed sexual development at age 18 yr. Although he had erections, there were no ejaculations. At age 19 yr he was referred to our service. He had an infantile penis and no palpable prostate. Testes measured 1 X 1.5 cm. 1 yr after the tests were performed plasma testosterone was 0.04 ,ug/100 ml, and he coml)lained of decreased libido. Fluoxymestrone, 5 mg/day, caused adequate secondary sexual development and galactorrhea.
Patient 5. N. W. did not walk until age 18 months and at 3 yr was noted to be deaf. At age 22 he was referred to us because of sexual immaturity. He had nerve deafness and hyporeflexia. His penis (5 cm) and testes (1 X 2 cm) were infantile, and there was no palpable prostatic tissue. After studies he was treated with HCG, 1000 IU three times weekly for 3 months followed by 4000 IU three times weekly for 2 months without detectable change in phallic or prostatic size. The plasma testosterone level after the second course of HCG was 0.23 ,ug/100 ml. The patient was then treated with fluoxymestrone and underwent secondary sexual development.
Patient 6. R. S. was treated with HCG at age 9 yr for bilateral inguinal testes. During this therapy he noted growth of facial, axillary, and pubic hair which stopped when the HCG was discontinued. He subsequently had erections but no ejaculations. At age 23 he was referred to our service. His penis was 5 cm and scrotal testes were 1 X 0.8 X 0.5 cm. No prostate tissue was palpable. The patient was then treated with HCG, 1000 IU twice weekly for 8 months. On this medication he noted gynecomastia, a slight increase in facial hair, and more frequent erections, but there were no ejaculations and no increase in prostate size. Plasma testosterone after 8 months of HCG therapy was 0.038 /lg/100 ml. Patient 7. H. R. was given a series of HCG injections for bilateral cryptorchidism at age 14 yr. On this medication the left testis descended into the scrotum, and there was an increase in stature (3 inches) and slight growth of both pubic hair and penis. Thereafter the patient did not undergo puberty, and there was no increase in height. At age 21 yr he was referred to us. He had an infantile penis and testes and a small prostate. The right testis was high in the inguinal canal. HCG administration resulted in further growth of pubic hair, and penis and prostate increased in size. At age 22 after a right orchiopexy, fluoxymestrone (5 mg/day) was begun, and secondary sexual development continued. At 27 yr of age fluoxymestrone was discontinued for 2 months, and the studies in Table I were performed.
